For consideration of USD 1.2 mn
Ipca Laboratories announced that its wholly owned subsidiary, Ipca Laboratories Inc. USA has acquired another 20% share capital of Bayshore Pharmaceuticals (Bayshore), a New Jersey limited liability company for cash consideration of USD 1.2 million. With this acquisition, Bayshore is now a wholly owned step-down subsidiary of the company.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
